Home > Riviste > La Rivista Italiana della Medicina di Laboratorio > Fascicoli precedenti > La Rivista Italiana della Medicina di Laboratorio 2020 Marzo;16(1) > La Rivista Italiana della Medicina di Laboratorio 2020 Marzo;16(1):4-6

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

L’OSSERVATORIO   

La Rivista Italiana della Medicina di Laboratorio 2020 Marzo;16(1):4-6

DOI: 10.23736/S1825-859X.19.00023-9

Copyright © 2019 EDIZIONI MINERVA MEDICA

lingua: Italiano

ISO 17822, la qualità per esami con amplificazione di acidi nucleici

Marco PRADELLA

SIPMeL, Castelfranco Veneto, Treviso, Italia



ISO, the International Organization for Standardization, is preparing document ISO/TS 17822-2 on the quality control of nucleic acid amplification techniques (NAAT). ISO 17822-2 takes into consideration many aspects that affect quality. ISO 17822 prescribes the use of control materials and describes different types of them. ISO 17822-2 states that the laboratory shall decide the appropriate type and frequency of use of internal and external controls, but says however that the results must remain within the pre-established limits, without saying how the limits should be fixed. Worldwide quality control in medical laboratories is often not performed correctly. Quality costs represent 22% of the laboratory’s direct costs. The SIPMeL Quality and Accreditation Commission has therefore produced its recommendations on quality control, with the transposition of ISO 15198: 2004, reconfirmed also in 2018. Diagnostic system manufacturers have a primary role in this activity. The guidelines for quality control are in the document Clinical Laboratory Standards Institute (CLSI) C24.


KEY WORDS: Quality control; Accreditation; Nucleic acid amplification techniques; Microbiology

inizio pagina